Net Loss per Share - Antidilutive Potential Common Shares (Details) |
9 Months Ended | |
|---|---|---|
|
Sep. 30, 2026
shares
|
Sep. 30, 2025
shares
|
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive potential common stock (in shares) | 11,804,344 | 11,970,633 |
| Metromile | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Conversion ratio | 0.05263 | 0.05263 |
| Options to purchase common stock | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive potential common stock (in shares) | 6,669,405 | 8,019,341 |
| Unvested restricted stock | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive potential common stock (in shares) | 5,134,939 | 3,538,323 |
| Warrants for common stock | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive potential common stock (in shares) | 0 | 412,969 |